InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Burgess Daniel d, 董事. Officer active across 2 companies, notably Nabriva Therapeutics plc. Aggregated, 4 filings have been logged. Breakdown: 0 buy · 2 sells. Total volume traded: €3k. History available since 28 July 2021. The latest transaction was disclosed on 7 January 2026 (Disposition). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Daniel D. Burgess is a Board Member at Nabriva Therapeutics plc. He contributes to the governance of the company by participating in strategic decision-making and ensuring operational compliance. His role is important for the success and growth of the company.